129 related articles for article (PubMed ID: 35594773)
41. Immune gene expression in head and neck squamous cell carcinoma patients.
Lecerf C; Kamal M; Vacher S; Chemlali W; Schnitzler A; Morel C; Dubot C; Jeannot E; Meseure D; Klijanienko J; Mariani O; Borcoman E; Calugaru V; Badois N; Chilles A; Lesnik M; Krhili S; Choussy O; Hoffmann C; Piaggio E; Bieche I; Le Tourneau C
Eur J Cancer; 2019 Nov; 121():210-223. PubMed ID: 31593831
[TBL] [Abstract][Full Text] [Related]
42. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
[TBL] [Abstract][Full Text] [Related]
43. Novel insight into mutational landscape of head and neck squamous cell carcinoma.
Gaykalova DA; Mambo E; Choudhary A; Houghton J; Buddavarapu K; Sanford T; Darden W; Adai A; Hadd A; Latham G; Danilova LV; Bishop J; Li RJ; Westra WH; Hennessey P; Koch WM; Ochs MF; Califano JA; Sun W
PLoS One; 2014; 9(3):e93102. PubMed ID: 24667986
[TBL] [Abstract][Full Text] [Related]
44. TP53 mutations in head and neck cancer.
Nathan CA; Khandelwal AR; Wolf GT; Rodrigo JP; Mäkitie AA; Saba NF; Forastiere AA; Bradford CR; Ferlito A
Mol Carcinog; 2022 Apr; 61(4):385-391. PubMed ID: 35218075
[TBL] [Abstract][Full Text] [Related]
45. Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.
Ock CY; Son B; Keam B; Lee SY; Moon J; Kwak H; Kim S; Kim TM; Jeon YK; Kwon SK; Hah JH; Lee SH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):873-83. PubMed ID: 26677030
[TBL] [Abstract][Full Text] [Related]
46. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
47. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
48. Novel prognostic value and potential utility of opioid receptor gene methylation in liquid biopsy for oral cavity cancer.
Ishikawa R; Imai A; Mima M; Yamada S; Takeuchi K; Mochizuki D; Shinmura D; Kita JY; Nakagawa T; Kurokawa T; Misawa Y; Nakanishi H; Takizawa Y; Misawa K
Curr Probl Cancer; 2022 Apr; 46(2):100834. PubMed ID: 35042636
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of FAT1 gene mutation and mRNA expression in patients with head and neck squamous cell carcinoma.
Kim SI; Woo SR; Noh JK; Lee MK; Lee YC; Lee JW; Ko SG; Eun YG
Mol Oncol; 2022 Apr; 16(8):1661-1679. PubMed ID: 34939311
[TBL] [Abstract][Full Text] [Related]
51. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY
J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563
[TBL] [Abstract][Full Text] [Related]
52. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
53. [Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck].
Golusinski P; Lamperska K; Pazdrowski J; Golusinski W
Otolaryngol Pol; 2011; 65(2):114-21. PubMed ID: 21735667
[TBL] [Abstract][Full Text] [Related]
54. PIK3CA mutations in head and neck squamous cell carcinoma.
Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
[TBL] [Abstract][Full Text] [Related]
55. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
Ma J; Fu Y; Tu YY; Liu Y; Tan YR; Ju WT; Pickering CR; Myers JN; Zhang ZY; Zhong LP
BMC Cancer; 2018 Jul; 18(1):758. PubMed ID: 30041611
[TBL] [Abstract][Full Text] [Related]
56. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
[TBL] [Abstract][Full Text] [Related]
57. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
[TBL] [Abstract][Full Text] [Related]
58. Preferential allelic deletion of RBSP3, LIMD1 and CDC25A in head and neck squamous cell carcinoma: Implication in cancer screening and early detection.
Sarkar S; Panda CK
Cancer Biol Ther; 2018 Jul; 19(7):631-635. PubMed ID: 29624473
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
[TBL] [Abstract][Full Text] [Related]
60. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
